Mitochondrial dysfunction may be a contributor to schizophrenia

Researchers at Rutgers and Emory University are gaining insights into how schizophrenia develops by studying the strongest-known genetic risk factor.

Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity

Researchers identified how SARS-CoV-2 targets and manipulates specific lung cells, using innovative techniques to trace the virus’s impact on the cells’ gene expression, revealing insights

April 15, 2024

Diet and Prostate Cancer; TTFields OK’d for NSCLC; Cancer Studies Retracted

A healthy diet in prostate cancer patients on active surveillance was associated with a reduced risk of progressing to a more advanced disease state. (JAMA

October 19, 2024

Long COVID’s lasting toll: Economic losses, healthcare strain, and the urgent need for better global policies

Study reviews the impact of long COVID on individuals, health systems, and global economies, highlighting the need for a coordinated, patient-centered approach for future research

August 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.